4-hydroxy-3-iodo-5-nitrophenylacetic acid-specific B-cell receptor (NIP-specific BCR) (NIP-specific BCR)

The 4-hydroxy-3-iodo-5-nitrophenylacetic acid-specific B-cell receptor (NIP-specific BCR) is a specialized immunoglobulin receptor that recognizes the synthetic hapten NIP with high affinity. It is a cornerstone of experimental immunology, primarily utilized in transgenic mouse models, such as the B1-8 strain, to study the fundamental processes of the humoral immune response (Reth et al., 1978). By providing a defined antigen-receptor pair, this system allows researchers to track B-cell activation, germinal center formation, and the progression of somatic hypermutation and affinity maturation in vivo (Cumano & Rajewsky, 1986). While the NIP-specific BCR is not a direct therapeutic target for human disease, it serves as an essential tool for evaluating vaccine strategies and understanding the mechanisms of B-cell tolerance and autoimmunity. Furthermore, the NIP-specific recognition domain has been adapted in synthetic biology to develop universal or switchable chimeric antigen receptor (CAR) T-cell platforms, where NIP-conjugated adapter molecules bridge the CAR-T cell to various tumor antigens (Ma et al., 2016). This receptor's signaling is mediated through the Ig-alpha/Ig-beta heterodimer, triggering intracellular pathways that govern B-cell fate and differentiation.

Other names

NP-specific B-cell receptor4-hydroxy-3-nitrophenylacetyl-specific BCRB1-8 B-cell receptor4-hydroxy-3-iodo-5-nitrophenylacetic acid-specific BCR

The receptor binds NIP-haptenated antigens, leading to BCR aggregation and activation of the Ig-alpha/Ig-beta (CD79A/CD79B) signaling complex, which initiates downstream cascades involving Syk, PLC-gamma-2, and PI3K.